RadNet, Inc.: management transactions · United States · SEC (Form 4)

About RadNet, Inc.

RadNet, Inc. is a U.S.-based leader in outpatient diagnostic imaging. The company is listed on NASDAQ in the United States under the ticker RDNT. Its business model combines a large network of fixed-site imaging centers with radiology services and, increasingly, a digital health platform. According to company disclosures, RadNet was founded in 1984 by a group of physicians and has evolved into a scaled national platform built around access, clinical quality, and operating efficiency. ([radnet.com](https://www.radnet.com/corp/about-radnet?utm_source=openai)) RadNet’s core operations include outpatient diagnostic services such as MRI, CT, X-ray, ultrasound, 3D mammography, and other imaging modalities. The company also emphasizes clinical and technology-enabled support services for referring physicians, hospitals, and payers. Its geographic footprint is entirely U.S.-based, with regional networks across major markets including California, New York, New Jersey, Delaware, Maryland, and Florida. RadNet describes itself as the largest national provider of freestanding outpatient imaging services by number of locations, with a sizable center network and more than 10 million outpatient procedures annually. ([radnet.com](https://www.radnet.com/corp/about-radnet?utm_source=openai)) From a competitive standpoint, RadNet’s appeal lies in scale, dense local coverage, and the ability to provide a multi-modality “one-stop shop” for referring physicians and health plans. That footprint supports negotiating leverage, patient convenience, and operational efficiency. The company also highlights its technology positioning, including radiology software capabilities and a growing digital health segment, which is becoming increasingly important as imaging workflows become more data-driven and integrated across care settings. ([radnet.com](https://www.radnet.com/corp/about-radnet?utm_source=openai)) Recent developments reinforce that strategy. RadNet reported record fourth-quarter 2025 revenue of $547.7 million and continued strong growth in its Digital Health segment. In the first quarter of 2026, management said the business rebounded after severe winter weather in the U.S. Northeast and raised its 2026 guidance for the imaging center business. For investors, RadNet is best viewed as a healthcare franchise listed on NASDAQ in the United States, with a defensive end-market and an additional growth vector tied to digitalization, workflow automation, and imaging network optimization. ([radnet.com](https://www.radnet.com/about-radnet/news/radnet-reports-fourth-quarter-2025-results-including-record-revenue-and-adjusted-ebitda-and-releases-2026-financial-guidance?utm_source=openai))